Enhanced non-inflammasome mediated immune responses by mannosylated zwitterionic-based cationic liposomes for HIV DNA vaccines
- 1 April 2016
- journal article
- Published by Elsevier in Biomaterials
- Vol. 85, 1-17
Abstract
No abstract availableKeywords
Funding Information
- Chinese Academy of Sciences (XDA09030301-3)
- National High-tech Research and Development Program (2014AA020708)
- National Natural Science Foundation of China (21304099, 51573188, 31522023)
This publication has 38 references indexed in Scilit:
- Multiple factors affect immunogenicity of DNA plasmid HIV vaccines in human clinical trialsVaccine, 2015
- In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populationsHuman Vaccines & Immunotherapeutics, 2015
- Cationic Lipid-Formulated DNA Vaccine against Hepatitis B Virus: Immunogenicity of MIDGE-Th1 Vectors Encoding Small and Large Surface Antigen in Comparison to a Licensed Protein VaccinePLOS ONE, 2014
- Enhancement of plasmid DNA immunogenicity with linear polyethylenimineEuropean Journal of Immunology, 2012
- Surface-Engineered Gold Nanorods: Promising DNA Vaccine Adjuvant for HIV-1 TreatmentNano Letters, 2012
- Clinical Applications of DNA Vaccines: Current ProgressClinical Infectious Diseases, 2011
- Superparamagnetic Nanoparticles for Effective Delivery of Malaria DNA VaccineLangmuir, 2011
- The use of layered double hydroxides as DNA vaccine delivery vector for enhancement of anti-melanoma immune responseBiomaterials, 2011
- A Phase 1/2 Study of a Multiclade HIV‐1 DNA Plasmid Prime and Recombinant Adenovirus Serotype 5 Boost Vaccine in HIV‐Uninfected East Africans (RV 172)The Journal of Infectious Diseases, 2010
- The use of PEGylated poly [2-(N,N-dimethylamino) ethyl methacrylate] as a mucosal DNA delivery vector and the activation of innate immunity and improvement of HIV-1-specific immune responsesBiomaterials, 2010